Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Shionogi, Inc. 

100 Campus Drive

Florham Park  New Jersey  07932  U.S.A.
Phone: 973-966-6900 Fax: n/a



 Company News
Egalet Earns $10 Million Milestone Payment Triggered By Advancement Of Shionogi, Inc.'s Abuse-Deterrent, Extended-Release Hydrocodone, S-718632, Using Egalet's GuardianTechnology 3/17/2015 7:06:26 AM
Shionogi, Inc. Release: Novel Siderophore Cephalosporin S-649266 Pre-Clinical Results Suggest Potent Activity Against Multidrug-Resistant Gram-Negative Pathogens 10/9/2014 12:31:38 PM
Shionogi, Inc. Announces Four Abstracts To Be Presented At The 25th Annual Meeting Of The North American Menopause Society (NAMS) In Washington, DC 10/1/2014 9:35:16 AM
Shionogi, Inc. Pledges To "Take Charge" In Honor Of Menopause Awareness Month 9/8/2014 9:16:20 AM
Noven Pharmaceuticals Inc. Enters Co-Promotion Agreement With Shionogi, Inc. For Brisdelle™ (Paroxetine) Capsules 1/13/2014 12:08:31 PM
Actress Virginia Madsen Partners With Shionogi, Inc. to Empower Postmenopausal Women to Break the Silence Around Painful Intercourse Due to Menopause 6/25/2013 10:28:18 AM
What Patient Harm? FDA Slams Shionogi, Inc. for Not Preparing Studies 5/28/2013 8:32:29 AM
Will Shionogi, Inc.'s Osphena Fix Female Sexual Dysfunction? 5/1/2013 8:09:15 AM
Shionogi, Inc. Selects QUMAS ComplianceSP on Microsoft SharePoint 2010 to Manage Quality Across the Organization 4/9/2013 12:20:55 PM
European Medicines Agency Accepts MAA Submission of Shionogi, Inc.'s Ospemifene for the Treatment of VVA 3/27/2013 11:32:51 AM